Introducing Elixir
Founded in 2002, Elixir Securities ("Elixir") is a London-based boutique corporate finance business specializing in the global healthcare, pharmaceutical and biotech sectors.
Elixir is focused on developing solutions for companies seeking to develop and execute their growth strategies either in part or entirely in Europe.
Our capabilities are aligned with the sector-specific financial challenges which these companies face. As scientists, first and foremost, we draw on a wealth of experience to provide our clients with solutions which not only reflect the demands of the financial markets, but also our understanding of the realities of the life sciences world.
"Primary markets" capabilities include public and private placements, PIPEs, secondary offerings, IPOs, pre-IPOs, buyouts/ins and special-situation deal structures, such as those which pre-fund corporate "buy-and-build" acquisition strategies. Elixir is also able to undertake Mergers/Acquisitions and product licensing mandates.
Securities which are available to companies may include term debt, fixed premium converts, variable priced converts, equity lines of credit and equity.
Elixir also helps smaller companies to identify and develop their key strategic messages and to prepare professional prospectuses (for product licensing purposes); private placement memorandums and marketing presentations.
Elixir News
CENES PHARMACEUTICALS PLACING TO RAISE £6.1M
CAMBRIDGE, July 27, 2007. CeNeS is pleased to announce that it proposes to raise approximately £6.1 million (before expenses) by means of a placing ("the Placing") of 5,789,137 new ordinary shares (the "Placing Shares") of 30 pence each ("New Ordinary Shares") at 105 pence per share....
ELIXIR VOTED HIGHEST RANKING BIOTECH 'INDEPENDENT' IN THE 2005 EUROPEAN THOMSON EXTEL SURVEY
LONDON, June 8, 2005. Elixir Securities, a London-based equity research company specialising in the global pharmaceutical and biotech sectors was the highest ranking 'Indepenent' Broker in the 2005 European Thomson Extel survey....
Read more news relating to Elixir »
Upcoming Conference
5th Annual Asia Pacific BioScience Forum London
Date TBC
Click here for information »
See you there...